Last Close
May 19  •  04:00PM ET
0.7174
Dollar change
-0.0269
Percentage change
-3.61
%
May 18, 1:02 PMQ1 widened loss and going concern warning trigger CPHI's 31% plunge.
Index
-
P/E
-
EPS (ttm)
-0.55
Insider Own
6.62%
Shs Outstand
40.52M
Perf Week
-19.64%
Market Cap
29.07M
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
37.84M
Perf Month
7.88%
Enterprise Value
32.46M
PEG
-
EPS next Q
-
Inst Own
0.06%
Perf Quarter
10.76%
Income
-3.55M
P/S
7.29
EPS this Y
-
Inst Trans
-6.29%
Perf Half Y
-51.98%
Sales
3.99M
P/B
0.78
EPS next Y
-
ROA
-11.87%
Perf YTD
-40.71%
Book/sh
0.92
P/C
171.00
EPS next 5Y
-
ROE
-15.99%
52W High
2.60 -72.38%
Perf Year
-66.79%
Cash/sh
0.00
P/FCF
193.80
EPS past 3/5Y
73.01% 53.14%
ROIC
-9.51%
52W Low
0.38 87.90%
Perf 3Y
-95.47%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-20.03% -17.53%
Gross Margin
-30.80%
Volatility
46.27% 24.21%
Perf 5Y
-99.75%
Dividend TTM
-
EV/Sales
8.14
EPS Y/Y TTM
75.39%
Oper. Margin
-90.13%
ATR (14)
0.17
Perf 10Y
-99.35%
Dividend Ex-Date
-
Quick Ratio
0.07
Sales Y/Y TTM
-7.07%
Profit Margin
-88.82%
RSI (14)
50.49
Recom
-
Dividend Gr. 3/5Y
- -
Current Ratio
0.28
EPS Q/Q
81.48%
SMA20
6.66%
Beta
1.02
Target Price
-
Payout
-
Debt/Eq
0.10
Sales Q/Q
-13.44%
SMA50
11.57%
Rel Volume
0.39
Prev Close
0.74
Employees
221
LT Debt/Eq
0.00
Earnings
-
SMA200
-41.95%
Avg Volume
282.33K
Price
0.72
IPO
Apr 17, 2002
Option/Short
No / Yes
EPS/Sales Surpr.
- -
Trades
Volume
110,020
Change
-3.61%
Date Action Analyst Rating Change Price Target Change
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $6
May-14-26 08:56AM
Apr-04-25 04:05PM
Dec-18-24 08:30AM
Dec-13-24 08:00AM
Aug-19-24 08:00AM
04:05PM Loading…
Feb-23-24 04:05PM
Nov-29-23 08:00AM
Aug-23-23 07:34PM
Aug-09-23 08:30AM
Feb-24-23 04:05PM
Dec-28-22 08:00AM
Dec-15-22 08:00AM
Dec-05-22 08:00AM
Dec-02-22 04:10PM
Oct-01-22 10:05PM
08:00AM Loading…
Jul-18-22 08:00AM
Jun-22-22 05:00PM
Mar-31-22 08:00AM
Nov-12-21 04:30PM
Aug-13-21 04:30PM
Aug-05-21 09:00AM
Jun-09-21 08:00AM
May-14-21 04:30PM
Apr-19-21 08:30AM
Mar-26-21 05:00PM
Nov-13-20 04:10PM
Oct-11-20 09:23AM
Sep-21-20 08:30AM
Aug-14-20 06:30AM
Aug-11-20 10:10AM
07:59PM Loading…
Jun-04-20 07:59PM
May-15-20 06:30AM
Apr-15-20 08:00AM
Apr-14-20 04:30PM
07:10AM
Apr-05-20 01:17AM
Mar-31-20 06:30AM
Mar-13-20 08:30AM
Mar-02-20 07:00AM
Dec-31-19 08:01AM
Nov-15-19 08:00AM
Oct-28-19 07:39AM
Sep-13-19 07:17AM
Sep-11-19 08:00AM
Sep-06-19 08:31AM
Aug-15-19 06:30AM
May-21-19 07:56PM
May-15-19 06:00AM
May-07-19 08:00AM
Mar-29-19 06:00AM
Jan-08-19 12:58PM
Nov-23-18 08:55AM
Nov-15-18 06:00AM
Nov-13-18 08:00AM
Nov-12-18 08:00AM
Oct-10-18 06:44PM
Aug-15-18 06:00AM
Aug-06-18 08:45AM
May-15-18 08:00AM
06:00AM
May-08-18 08:00AM
Apr-06-18 07:40AM
Apr-05-18 07:10AM
Apr-03-18 06:00AM
Mar-22-18 08:00AM
Dec-01-17 07:58AM
Nov-15-17 06:00AM
Nov-08-17 12:20PM
Nov-07-17 08:00AM
Oct-24-17 03:48PM
Sep-26-17 12:03PM
Sep-14-17 07:40AM
Sep-12-17 04:05PM
Aug-16-17 10:08AM
Aug-15-17 06:00AM
Aug-08-17 06:00AM
May-24-17 09:18AM
May-17-17 08:30AM
May-12-17 06:00AM
May-08-17 06:00AM
Apr-04-17 08:41AM
Mar-31-17 06:11AM
06:00AM
Mar-27-17 06:00AM
Dec-28-16 04:06PM
Dec-13-16 04:08PM
Dec-02-16 04:11PM
Nov-22-16 01:04PM
Nov-18-16 11:50AM
Nov-15-16 06:00AM
Nov-14-16 04:12PM
Nov-07-16 08:00AM
Aug-12-16 06:00AM
Aug-11-16 04:27PM
Aug-01-16 06:00AM
Jun-06-16 12:12PM
May-17-16 06:00AM
May-16-16 05:17PM
May-05-16 06:00AM
Apr-05-16 11:33AM
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.
PresidentMs. Zhilin Li
BOD Secretary & IR ManagerMs. Huang Na C.F.A.